Next Article in Journal
The Cuprizone Model: Dos and Do Nots
Next Article in Special Issue
The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis
Previous Article in Journal
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
Previous Article in Special Issue
T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 31 March 2020 12:33 CEST Original file -
article xml uploaded. 31 March 2020 12:33 CEST Update https://www.mdpi.com/2073-4409/9/4/842/xml
article pdf uploaded. 31 March 2020 12:33 CEST Version of Record https://www.mdpi.com/2073-4409/9/4/842/pdf
article html file updated 31 March 2020 12:35 CEST Original file -
article html file updated 8 May 2020 12:43 CEST Update -
article html file updated 21 July 2022 00:28 CEST Update https://www.mdpi.com/2073-4409/9/4/842/html
Back to TopTop